Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid TumorsAdnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, rectal disorder, skin disorderRecruitingPhase 12025-06-05NCT05740956

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Jiangsu Hansoh Pharmaceutical Co., Ltd.59

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cancer Hospital Chinese Acedemy of Medical SciencesBeijingChina1